The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation study

BACKGROUND: Sequence symmetry analysis (SSA) is a potential tool for rapid detection of adverse drug events (ADRs) associated with newly marketed medicines utilizing computerized claims data. SSA is robust to patient specific confounders but it is sensitive to the underlying utilization trends in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Pratt, Nicole L, Ilomäki, Jenni, Raymond, Chris, Roughead, Elizabeth E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035856/
https://www.ncbi.nlm.nih.gov/pubmed/24886247
http://dx.doi.org/10.1186/1471-2288-14-66

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035856/
https://www.ncbi.nlm.nih.gov/pubmed/24886247
http://dx.doi.org/10.1186/1471-2288-14-66

Ejemplares similares